INHIBRX BIOSCIENCES INC

Insider option exercise at Inhibrx Biosciences signals leadership confidence amid volatile market, offering insights into biotech valuation, reimbursement strategies and digital‑health adoption.

Inhibrx Biosciences insider buys, institutional sales, and a 59 % price jump raise questions about confidence and valuation in this biotech firm’s future.